EUVIMEDEUVIMED entdecken
Crossref

Duffy Antigen Status, Hydroxyurea Dosing, and Disease Severity in Children and Young Adults With Sickle Cell Disease

Alison Celello iD, Christopher McKinney iD

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Alison Celello und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Hydroxyurea, Anemia, Sickle Cell, Duffy Blood-Group System, Antisickling Agents. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most patients with sickle cell disease (SCD) also have the Duffy null red blood cell phenotype, often leading to lower absolute neutrophil counts (ANC). Hydroxyurea titration in SCD is largely driven by ANC. Hydroxyurea maximum tolerated dose (MTD) attainment, MTD dosage, and metrics of SCD severity based on both MTD attainment and Duffy antigen status were analyzed in pediatric and young adult patients. Rates of vasoocclusive episodes and emergency room visits for complications of SCD were increased in the total cohort of Duffy antigen positive patients and in Duffy antigen positive patients who attained MTD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxyureaAnemia, Sickle CellDuffy Blood-Group SystemAntisickling AgentsReceptors, Cell SurfaceHumansChildAdolescentFemaleMaleYoung AdultChild, PreschoolVaso-Occlusive CrisesSeverity of Illness IndexMaximum Tolerated DoseAdult

Stichwörter der Autor:innen

Duffy antigenhydroxyureasickle cell disease

Substanzen

HydroxyureaDuffy Blood-Group SystemAntisickling AgentsACKR1 protein, humanReceptors, Cell Surface

Autor:innen und Institutionen

  • University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.

ORCID-Profile: Alison Celello, Christopher McKinney

Zitieren

APA

Celello, A., & McKinney, C. (2026). Duffy Antigen Status, Hydroxyurea Dosing, and Disease Severity in Children and Young Adults With Sickle Cell Disease. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70577

Vancouver

Celello A, McKinney C. Duffy Antigen Status, Hydroxyurea Dosing, and Disease Severity in Children and Young Adults With Sickle Cell Disease. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70577

BibTeX
@article{Celello2026,
  author = {Celello, Alison and McKinney, Christopher},
  title = {Duffy Antigen Status, Hydroxyurea Dosing, and Disease Severity in Children and Young Adults With Sickle Cell Disease},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70577}
}
Kostenlos starten →